Successful Online Exercise Intervention Studies for Individuals With Intellectual Disabilities Including Down Syndrome: Best Practices and Recommendations.
Thessa Hilgenkamp, Amy Bodde, Sarah Mann and 4 others
PMID 40492527WHAT IT FOUND
Two research teams recommend using small online exercise groups, consistent routines, and visual cues for adults with intellectual disabilities.
They advise checking home support needs first, as some participants prefer independence over caregiver involvement during sessions.
Key findings
01The authors recommend small group sizes of up to 10 participants for online exercise to ensure safety and allow for social interaction.
02For individuals with Down syndrome, successful delivery relies on consistent routines, visual cues, and music, rather than varying exercises frequently.
03Caregiver involvement should be assessed individually, as some young adults with Down syndrome explicitly reject family presence during exercise classes.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a consensus paper based on the authors' own experiences and previously published studies, not a new systematic review or meta-analysis. The recommendations are derived from two specific research centres, which may limit generalisability to other clinical settings. The paper does not report new outcome data, so it cannot confirm the efficacy of these specific best practices compared to other methods.
Declared interests
The authors declare no conflicts of interest. The work was funded by the National Institutes of Health.
The easy way to misread this
Do not interpret these recommendations as evidence that online exercise improves health outcomes. This paper describes how to deliver such programmes effectively based on the authors' experience, but it does not present new trial data proving efficacy.